Tag Archive for: gastric cancer screening

Stomach Cancer Screening | How Asian and Latinx Patients Can Self-Advocate

Stomach Cancer Screening | How Asian and Latinx Patients Can Self-Advocate from Patient Empowerment Network on Vimeo.

How can Asian and Latinx patients self-advocate for gastric cancer screening? Expert Dr. Joo Ha Hwang from Stanford Medicine shares advice for how patients can discuss gastric cancer screening with their provider and how providers should be engaging with patients for better care.

[ACT]IVATION TIP

“…especially if you come from Korea, Japan, where they actually have instituted national screening, with endoscopy, we actually have U.S. guidelines that state that if you come from a country whose guidelines state you should have endoscopy, then you should also have endoscopy, we should be following your home of origins guidelines for you and so, those patients should also have endoscopy.”

See More from [ACT]IVATED Gastric Cancer

Related Resources:

How Biomarkers Might Impact Future Stomach Cancer Care

How Biomarkers Might Impact Future Stomach Cancer Care

What Are Key Risk Factors for Stomach Cancer?

What Are Key Risk Factors for Stomach Cancer?

Potential Impact of Artificial Intelligence on Stomach Cancer Detection and CarePotential Impact of Artificial Intelligence on Stomach Cancer Detection and Care

Transcript:

Lisa Hatfield:

So in the United States, we do have many people from the Asian and Hispanic communities who may be at higher risk for gastric cancer, do you suggest that they talk to their provider about getting screened? And how might they phrase that question? Can I get screened for the H. pylorI? So if you had a patient who wanted to be screened or is interested in getting screened, how might they approach their provider in asking for the screening for gastric cancer or H. pylori?

Dr. Joo Ha Hwang:

I think the first step is to get tested for H. pylori, and pretty much, everyone who is, an immigrant to the U.S. is at much higher risk for having H. pylori, in the past, we used to say that the people from Asia, immigrants from Asia had an 80 percent risk of having H. pylori, from Mexico, it was more like around 60 percent, United States, it was in the 20 to 30 percent, it’s probably less than that now.

So worldwide, prevalence of H. pylori is certainly going down but again, providers should know this is something that is taught in medical school, is areas that are, endemic with H. pylori and providers should also know that, H. pylori is a carcinogen, and so if a patient just comes up in and says I’m worried about having H. pylori, I come from a high-risk population, it really shouldn’t be difficult to get tested for H. pylori, furthermore, if they have any symptoms, especially any epigastric pain what we call dyspepsia that should also trigger the provider to go ahead and test for H. pylori, because that’s part of the algorithm. So I think that all of these, it shouldn’t be difficult to engage a provider on that particular issue.

Lisa Hatfield:

So it is okay and appropriate for a patient to approach their provider and ask that question? So I appreciate that.

Dr. Joo Ha Hwang:

I think it’s important and I think that patients need to be their own advocates, because I have heard of instances where providers have been reluctant and in certain systems they’re discouraged from further testing, because it’s a capitated system. I think H. pylori testing is not that difficult, sometimes if patients want endoscopy, it can be, more challenging but again, especially if you come from Korea, Japan, where they actually have instituted national screening, with endoscopy, we actually have U.S. guidelines that state that if you come from a country whose guidelines state you should have endoscopy, then you should also have endoscopy, we should be following your home of origins guidelines for you and so, those patients should also have endoscopy.

But the challenge with that is that they’re going to end up paying for it, because it’s not typically covered by insurance or it’s not fully covered by insurance so you’d probably have to pay a copay, for something like that at this time.

Lisa Hatfield:

I have a friend who’s dealing with her father who lives in Korea, she’s from Korea, has been here about two, five years. He has stomach cancer. So we’ve been having this discussion, and that’s why I thought I’d ask that last question. She said she sometimes is afraid to approach her provider…

Dr. Joo Ha Hwang:

If you’re afraid to approach your provider, you need a different provider.

Lisa Hatfield:

Well, that’s a good suggestion too.

Dr. Joo Ha Hwang:

No, no. We’re supposed to work with you and listen to you and again, I go around and give a lot of talks to patient groups, and I like engaging in these types of activities, because I think the more information patients have, the more that they can talk with their physicians, and oftentimes patients know more than their physicians do, because they’ve done a lot more research. And hopefully you have a physician with some hubris who will listen to the patient and if they don’t know, they’ll kind of look things up, so yeah.

Lisa Hatfield:

Yeah. I appreciate that, thank you.

Dr. Joo Ha Hwang:

My pleasure.


Share Your Feedback

How Biomarkers Might Impact Future Stomach Cancer Care?

How Biomarkers Might Impact Future Stomach Cancer Care from Patient Empowerment Network on Vimeo.

How might biomarkers impact the future of stomach cancer care? Expert Dr. Joo Ha Hwang from Stanford Medicine discusses the status of biomarkers in gastric cancer research and how gastric cancer screening and health outcomes in the U.S. compare to the rest of the world. 

See More from [ACT]IVATED Gastric Cancer

Related Resources:

What Are Key Risk Factors for Stomach Cancer?

What Are Key Risk Factors for Stomach Cancer?

Can Stomach Cancer Risk Be Reduced by Treatment and Lifestyle Changes?

Can Stomach Cancer Risk Be Reduced by Treatment and Lifestyle Changes?

What Stomach Cancer Care Obstacles Do Asian and Latinx Patients Face?

What Stomach Cancer Care Obstacles Do Asian and Latinx Patients Face?

Transcript:

Lisa Hatfield:

Dr. Hwang, can you speak to emerging biomarkers for early gastric cancer that have shown the most promise in your research? And how might these biomarkers influence future therapeutic strategies and outcomes for gastric cancer patients?

Dr. Joo Ha Hwang:

Yeah, it’s still very, very early days for biomarkers in the field of gastric cancer. Unlike other more prevalent tumors in the United States, and this has to go towards funding for research. Gastric cancer research has been fairly underfunded in the United States. The incidence of gastric cancer is not low, actually. There’s a lot more research in esophageal cancer and Barrett’s esophagus, but actually the prevalence or the incidence of esophageal cancer is much lower than stomach cancer.

So, fortunately the funding environment is slowly starting to change. There are active studies ongoing, both in the United States and abroad on looking at biomarkers. But I would say it’s too preliminary to even suggest that there are any specific biomarkers out there that might help to detect early gastric cancer.

And that’s either by tissue biopsy or anything that might be in the blood. But it will come, I mean, it’s coming for other diseases like colon cancer. So I’m confident that eventually we’ll see biomarkers come for detection of early gastric cancer, and we really need these biomarkers, or we need to be doing something because right now outcomes in the United States for gastric cancer are some of the worst in the world because we really don’t do anything for gastric cancer.

For example, the five-year overall survival for gastric cancer, if you’re diagnosed to it within the U.S., is only 30 percent. But if you’re in Korea, Japan, the overall five-year survival is somewhere close to 70 percent. And the single reason for that is the stage of diagnosis. Japan and Korea have screening programs to detect early gastric cancer, and in the United States we really don’t do anything. And so there’s a lot of ground that can be made up. And what’s frustrating for me is that this is a very curable cancer. And there are pre-malignant conditions that we know of that we can survey for, but right now the general policy in the United States is don’t do anything. So we really need to change that.


Share Your Feedback

How Does Gastric Cancer Screening Differ for High-Risk Groups?

How Does Gastric Cancer Screening Differ for High-Risk Groups? from Patient Empowerment Network on Vimeo.

 Is gastric cancer screening different for some high-risk groups? Expert Dr. Jun Gong from Cedar-Sinai Medical Center shares how screening guidelines are evolving for some high-risk patient groups and advice to patients to ensure essential screening occurs.

[ACT]IVATION Tip

“…understanding whether you are in a specific high-risk subgroup it’s important to ask, whether diet and lifestyle can contribute to these risk factors are important to ask, and whether there is a risk of familial or hereditary causes of stomach cancer is important to ask as well. For us as oncologists to guide you to our supportive services and down the right path to address all of these concerns.”

Download Resource GuideDescargar guía de recursos

See More from [ACT]IVATED Gastric Cancer

Related Resources:

Addressing Elevated Gastric Cancer Risks in Asian and Hispanic Communities

What Gastric Cancer Challenges Do Asian and Hispanic Groups Face?

How Can Gastric Cancer Patients in Rural Areas Access Specialists?

Transcript:

Lisa:

Are there any screening tests that are recommended for anyone who might be in a group that’s known to have a higher incidence of gastric cancer?

Dr. Jun Gong:

Screening for stomach cancer in the U.S. is very evolving. It’s somewhat controversial. Unlike in East Asia and parts of the world where they’ve actually implemented standard endoscopic screening protocols as young as 40 or age 50. Here in the U.S., there hasn’t been any formal screening guidelines implemented for stomach cancer.

However, a lot of consensus groups recognize the high-risk subgroups of stomach cancer and in these risk factor, high-risk factor groups, especially if you have a family member a first-degree family member with stomach cancer or you’re a part of one of these ethnic groups that are at high risk, they do encourage screening to be discussed with your provider. And this can entail endoscopy surveillance as well.

So my activation tip regarding risk factors is to always inquire whether from your provider or from ancillary staff.  It’s very common for us to refer our patients as well to cancer nutritionists, dieticians as well, in addition to going over what may be some possible familial or hereditary risk, if we sense that a strong family history is present.

And this is where referrals to genetic counselors are available. But understanding whether you are in a specific high-risk subgroup it’s important to ask, whether diet and lifestyle can contribute to these risk factors are important to ask, and whether there is a risk of familial or hereditary causes of stomach cancer is important to ask as well. For us as oncologists to guide you to our supportive services and down the right path to address all of these concerns.

Share Your Feedback

Do Gastric Cancer Risk Factors Differ Among Hispanic Communities?

Do Gastric Cancer Risk Factors Differ Among Hispanic Communities? from Patient Empowerment Network on Vimeo.

Are there gastric cancer risk factors that differ for Hispanic communities? Expert Dr. Jun Gong from Cedar-Sinai Medical Center discusses risk factors for Hispanic and other higher risk stomach cancer groups.

Download Resource GuideDescargar guía de recursos

See More from [ACT]IVATED Gastric Cancer

Related Resources:

What Early Phase Gastric Cancer Trials Are Showing Promise?

Expert Guidance: Stomach Cancer Basics for Newly Diagnosed Patients

How Is Gastric Cancer Screening and Care Impacted by Culture?

Transcript:

Lisa:

Are there any specific risk factors for gastric cancer that are more prevalent in Hispanic communities compared to other ethnic groups?

Dr. Jun Gong:

So this is an interesting question in terms of risk factors and certain ethnic groups. We’ve realized that actually gastric cancer is highly prevalent in East Asia. And there, the risk factors seem to be more diet-related. But then when you look on the Western side of the world, it’s different risk factors that exist for stomach cancer. You always have familial risk. These are genetic, ancestral, or hereditary causes of stomach cancer, which are fairly rare. And this is independent of geography.

But here on the West, we tend to see more of risk factors related to the Western lifestyle. Here, gastritis or chronic gastritis, heartburn, longstanding inflammation is a risk factor. Heavy smoking, heavy alcohol use, and obesity are emerging risk factors for stomach cancer as well. And also, we have a very unique risk factor in a bacteria called H. pylori that is known globally to be a risk factor for gastric cancer.

And we’ve done research on this in that although the demographics in the U.S. is very diverse, we do see that Asians and Hispanics and African Americans compose higher risk groups for stomach cancer when compared to non-Hispanic whites. And in certain ethnic groups such as the Koreans, it can be as much as five times the risk for non-Hispanic whites. And we think it is due to these unique variations in H. pylori risk across the different races. We’ve done research at Cedars-Sinai where we’re looking at the Hispanic population and we’ve seen over time that actually, in addition to Hispanic populations being at higher risk for stomach cancer, it seems to be affecting a younger group and in particular younger females.

So we’re looking into this kind of new epidemiologic evidence as to why stomach cancer in Hispanics is becoming younger in onset and tends to have a predilection for females. And these patients however, if they are afforded the correct treatment and the timely treatment, their outcomes are just as good as the non-Hispanic counterparts. So this is an emerging topic and a very important topic in my opinion.

Share Your Feedback